Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06359314 · ClinicalTrials.gov registry record · NA
Anxiety Lowering and Deprescribing Through Emotion Regulation
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT06359314 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 33 participants.
The verdict
NCT06359314, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test ALDER (Anxiety Lowering and Deprescribing through Emotion Regulation), an online self-guided positive emotion intervention, in patients over the age of 65 who are candidates for benzodiazepine receptor agonist (BZRA, commonly called benzos, or z-drugs) deprescribing. The main questions it aims to answer are: * Is ALDER relevant to and satisfactory for older adult BZRA users? * Does ALDER help to increase positive emotions and decrease anxiety, trouble sleeping, and use of BZRA medications? Participants will complete the 5-week online self-guided ALDER intervention as well as two survey assessments, one before the intervention and one after.
Interventions
- BEHAVIORAL ALDER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-05-16 |
| Est. Completion | 2024-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06359314
The ClinicalTrials.gov registry entry for NCT06359314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ALDER is the first listed.
NCT06359314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06359314 about?
NCT06359314 is a clinical study titled "Anxiety Lowering and Deprescribing Through Emotion Regulation". The goal of this clinical trial is to test ALDER (Anxiety Lowering and Deprescribing through Emotion Regulation), an online self-guided positive emotion intervention, in patients over the age of 65 who are candidates for benzodiazepine receptor agonist (BZRA, commonly called benzos, or z-drugs) depr...
What is the current status of trial NCT06359314?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2024-05-16. Estimated completion is 2024-09-10.
What interventions are being tested in trial NCT06359314?
The interventions under investigation include: ALDER (BEHAVIORAL).
Who is sponsoring clinical trial NCT06359314?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.